Why the study?
Viral myocarditis and subsequent dilated cardiomyopathy remain challenging to diagnose and treat, and knowledge regarding treatment and management is still incomplete.
This review provides a comprehensive overview of the cardiovascular consequences of viral infections, highlighting the evolving understanding of viral myocarditis and the impact of SARS-CoV-2.
No takes yet. Share an insight, caveat, or question.
Viral myocarditis remains diagnostically challenging; leaves open whether molecular advances improve outcomes or guide therapy.
Schultheiß et al. (2021) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: